BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16195120)

  • 21. Expanding the limits of bibliotherapy for panic disorder: randomized trial of self-help without support but with a clear deadline.
    Nordin S; Carlbring P; Cuijpers P; Andersson G
    Behav Ther; 2010 Sep; 41(3):267-76. PubMed ID: 20569776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of change in cognitive therapy for panic disorder with agoraphobia.
    Hoffart A; Sexton H; Hedley LM; Martinsen EW
    J Behav Ther Exp Psychiatry; 2008 Sep; 39(3):262-75. PubMed ID: 17727812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapists' emotional reactions to patients as a mediator in cognitive behavioural treatment of panic disorder with agoraphobia.
    Hoffart A; Hedley LM; Thornes K; Larsen SM; Friis S
    Cogn Behav Ther; 2006; 35(3):174-82. PubMed ID: 16952901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic effectiveness measures: sensitivity to symptom change in anxiety disorders.
    Perini SJ; Slade T; Andrews G
    J Affect Disord; 2006 Feb; 90(2-3):123-30. PubMed ID: 16337690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the clinical utility of agoraphobia in the context of panic disorder.
    Schmidt NB; Cromer KR
    Depress Anxiety; 2008; 25(2):158-66. PubMed ID: 17351905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders.
    van Balkom AJ; van Boeijen CA; Boeke AJ; van Oppen P; Kempe PT; van Dyck R
    Depress Anxiety; 2008; 25(5):408-15. PubMed ID: 17960642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia.
    Siegmund A; Köster L; Meves AM; Plag J; Stoy M; Ströhle A
    J Psychiatr Res; 2011 Mar; 45(3):339-46. PubMed ID: 20673917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marital predictors of symptom severity in panic disorder with agoraphobia.
    Marcaurelle R; Bélanger C; Marchand A; Katerelos TE; Mainguy N
    J Anxiety Disord; 2005; 19(2):211-32. PubMed ID: 15533705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-day, intensive cognitive-behavioral therapy for panic disorder: a case study.
    Deacon B
    Behav Modif; 2007 Sep; 31(5):595-615. PubMed ID: 17699120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic indices with brief and standard CBT for panic disorder: I. Predictors of outcome.
    Dow MG; Kenardy JA; Johnston DW; Newman MG; Taylor CB; Thomson A
    Psychol Med; 2007 Oct; 37(10):1493-502. PubMed ID: 17493294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are there gender differences in catastrophic appraisals in panic disorder with agoraphobia?
    Starcevic V; Latas M; Kolar D; Berle D
    Depress Anxiety; 2007; 24(8):545-52. PubMed ID: 17131303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder.
    Nadiga DN; Hensley PL; Uhlenhuth EH
    Depress Anxiety; 2003; 17(2):58-64. PubMed ID: 12621593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.
    Vos SP; Huibers MJ; Diels L; Arntz A
    Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An effectiveness study of group therapy for anxiety disorders.
    van Ingen DJ; Novicki DJ
    Int J Group Psychother; 2009 Apr; 59(2):243-51. PubMed ID: 19441969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions.
    Goldstein AJ; de Beurs E; Chambless DL; Wilson KA
    J Consult Clin Psychol; 2000 Dec; 68(6):947-56. PubMed ID: 11142547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary investigation of the effects of cognitive behavioral therapy for panic disorder on gastrointestinal distress in patients with comorbid panic disorder and irritable bowel syndrome.
    Gros DF; Antony MM; McCabe RE; Lydiard RB
    Depress Anxiety; 2011 Nov; 28(11):1027-33. PubMed ID: 21770001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.
    Nagy LM; Krystal JH; Charney DS; Merikangas KR; Woods SW
    J Clin Psychopharmacol; 1993 Feb; 13(1):16-24. PubMed ID: 8098050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia.
    Mitte K
    J Affect Disord; 2005 Sep; 88(1):27-45. PubMed ID: 16005982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of panic disorder and agoraphobia in Europe.
    Goodwin RD; Faravelli C; Rosi S; Cosci F; Truglia E; de Graaf R; Wittchen HU
    Eur Neuropsychopharmacol; 2005 Aug; 15(4):435-43. PubMed ID: 15925492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic costs of full-blown and subthreshold panic disorder.
    Batelaan N; Smit F; de Graaf R; van Balkom A; Vollebergh W; Beekman A
    J Affect Disord; 2007 Dec; 104(1-3):127-36. PubMed ID: 17466380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.